TSHR and thanatophoric dysplasia: However, the authors found it difficult to explain the TD phenotype in the remaining three patients bearing monoallelic TSHR and FOXE1 deletions [15], especially as they did not identify a second pathogenic allele (i.e., by whole-gene sequencing) in these patients.